Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie I Bouwer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Breast (Edinburgh, Scotland)|May 4, 2020
Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practiceNathalie I Bouwer, Agnes Jager, Crista Liesting, et al.
Cardiovascular Ultrasound|November 10, 2021
2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumabNathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.
Cardio-Oncology (London, England)|March 11, 2020
NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumabNathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.
European Journal of Epidemiology|March 22, 2023
Risk of cancer after ST-segment-elevation myocardial infarctionMaarten J G Leening, Nathalie I Bouwer, M Arfan Ikram, et al.
International Journal of Cancer|April 11, 2022
The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fractionNathalie I Bouwer, Tessa G Steenbruggen, Hánah N Rier, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Breast (Edinburgh, Scotland)|May 4, 2020
Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practiceNathalie I Bouwer, Agnes Jager, Crista Liesting, et al.
Cardiovascular Ultrasound|November 10, 2021
2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumabNathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.
Cardio-Oncology (London, England)|March 11, 2020
NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumabNathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.
European Journal of Epidemiology|March 22, 2023
Risk of cancer after ST-segment-elevation myocardial infarctionMaarten J G Leening, Nathalie I Bouwer, M Arfan Ikram, et al.
International Journal of Cancer|April 11, 2022
The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fractionNathalie I Bouwer, Tessa G Steenbruggen, Hánah N Rier, et al.
Pageof 1